HOUGHTON MIFFLIN HARCOURT CO (HMHC)

Common Stock

21.03  +0.02 (+0.1%)

After market: 21.12 +0.09 (+0.43%)

Fundamental Rating

2

HMHC gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 66 industry peers in the Diversified Consumer Services industry. HMHC may be in some trouble as it scores bad on both profitability and health. HMHC is valied quite expensively at the moment, while it does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

In the past year HMHC was profitable.
In the past 5 years HMHC reported 4 times negative net income.
In the past 5 years HMHC always reported a positive cash flow from operatings.

1.2 Ratios

Industry RankSector Rank
ROA 10.82%
ROE 64.63%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 5.41%
PM (TTM) 20.32%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, HMHC has more shares outstanding
Compared to 1 year ago, HMHC has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -1.16, we must say that HMHC is in the distress zone and has some risk of bankruptcy.
A Debt/Equity ratio of 0.96 indicates that HMHC is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF N/A
Altman-Z -1.16
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

HMHC has a Current Ratio of 1.39. This is a normal value and indicates that HMHC is financially healthy and should not expect problems in meeting its short term obligations.
HMHC has a Quick Ratio of 1.18. This is a normal value and indicates that HMHC is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.39
Quick Ratio 1.18

4

3. Growth

3.1 Past

HMHC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 104.02%, which is quite impressive.
HMHC shows a small growth in Revenue. In the last year, the Revenue has grown by 5.80%.
Measured over the past years, HMHC shows a decrease in Revenue. The Revenue has been decreasing by -4.05% on average per year.
EPS 1Y (TTM)104.02%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q45.45%
Revenue 1Y (TTM)5.8%
Revenue growth 3Y-7.38%
Revenue growth 5Y-4.05%
Revenue growth Q2Q-12.18%

3.2 Future

HMHC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 67.54% yearly.
The Revenue is expected to grow by 2.84% on average over the next years.
EPS Next Y388.14%
EPS Next 2Y201.14%
EPS Next 3Y95.59%
EPS Next 5Y67.54%
Revenue Next Year3.98%
Revenue Next 2Y3.95%
Revenue Next 3Y3.37%
Revenue Next 5Y2.84%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

2

4. Valuation

4.1 Price/Earnings Ratio

HMHC is valuated quite expensively with a Price/Earnings ratio of 300.43.
HMHC's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.73.
Based on the Price/Forward Earnings ratio of 61.55, the valuation of HMHC can be described as expensive.
The average S&P500 Price/Forward Earnings ratio is at 20.41. HMHC is valued rather expensively when compared to this.
Industry RankSector Rank
PE 300.43
Fwd PE 61.55

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.11

4.3 Compensation for Growth

HMHC's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as HMHC's earnings are expected to grow with 95.59% in the coming years.
PEG (NY)0.77
PEG (5Y)N/A
EPS Next 2Y201.14%
EPS Next 3Y95.59%

0

5. Dividend

5.1 Amount

No dividends for HMHC!.
Industry RankSector Rank
Dividend Yield N/A

HOUGHTON MIFFLIN HARCOURT CO

NASDAQ:HMHC (4/6/2022, 7:00:02 PM)

After market: 21.12 +0.09 (+0.43%)

21.03

+0.02 (+0.1%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.69B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 300.43
Fwd PE 61.55
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.77
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 10.82%
ROE 64.63%
ROCE
ROIC
ROICexc
ROICexgc
OM 5.41%
PM (TTM) 20.32%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.39
Quick Ratio 1.18
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)104.02%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y388.14%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)5.8%
Revenue growth 3Y-7.38%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y